Swaza Inc Selected as One of 13 Companies Worldwide to Join DIANA’s Prestigious 2025 Health and Human Performance Cohort
Swaza Inc. selected for DIANA’s 2025 cohort, recognized for innovative therapeutics enhancing resilience to respiratory threats. MOUNTAIN VIEW, CA, UNITED STATES, January 13, 2025 /EINPresswire.com/ -- Swaza Inc., a pioneer in regenerative therapeutics for oxygen delivery, is proud to announce its selection as one of 13 global companies to join the 2025 Health and Human Performance cohort of the Defence Innovation Accelerator for the North Atlantic (DIANA). This honor recognizes Swaza’s groundbreaking …